Pfizer CEO pockets $33 million for 2022 after 36% pay rise (NYSE:PFE)

Winning McNamee

Pfizer (NYSE: PFE) CEO and Chairman Albert Bourla is likely to become one of the highest earning CEOs in the pharmaceutical industry in 2022 after the pharmaceutical giant raised his total compensation to $33.0 million, earning him a $33.0 million raise. salary of about 36% last year.


Leave a Reply

Your email address will not be published. Required fields are marked *